CAS 1239729-06-6 MFCD339729066

化学结构图

1239729-06-6
SMILES:

相关文献及参考

  • [2]. Bhat L, et al. Evaluation of the effects of RP5063, a novel, multimodal, serotonin receptor modulator, as single-agent therapy and co-administrated with sildenafil, bosentan, and treprostinil in a monocrotaline-induced pulmonary arterial hypertension rat model.Eur J Pharmacol. 2018 May 15;827:159-166.
  • [3]. L. Bhat,et al. Rp5063 Prevents Monocrotaline Induced Pulmonary Arterial Hypertension In Rats.
  • [1]. Reviva Pharmaceuticals Reports RP5063 Positive Efficacy Results for Memory Deficits
  • [1]. Reviva Pharmaceuticals Reports RP5063 Positive Efficacy Results for Memory Deficits
  • [2]. Bhat L, et al. Evaluation of the effects of RP5063, a novel, multimodal, serotonin receptor modulator, as single-agent therapy and co-administrated with sildenafil, bosentan, and treprostinil in a monocrotaline-induced pulmonary arterial hypertension rat model.Eur J Pharmacol. 2018 May 15;827:159-166.
  • [3]. L. Bhat,et al. Rp5063 Prevents Monocrotaline Induce

系列性分类


相关产品推荐